RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods

Area of Science:

• Molecular Biology
• Infectious Diseases
• Biotechnology

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, necessitates accurate and rapid diagnostics.
• Current gold standard, RT-qPCR, requires specialized labs and personnel, limiting accessibility.
• Clustered regularly interspaced short palindromic repeats (CRISPR) technology offers potential for sensitive, specific, and rapid molecular diagnostics.

Purpose of the Study:

• To review and summarize the application of CRISPR-based diagnostic techniques for SARS-CoV-2 detection.
• To highlight the integration of CRISPR with reverse-transcription loop-mediated isothermal amplification (RT-LAMP).
• To assess the potential of these combined methods as rapid and accessible COVID-19 diagnostic tools.

Main Methods:

• Literature review of CRISPR-based diagnostic techniques for SARS-CoV-2.
• Focus on methods combining CRISPR with reverse-transcription loop-mediated isothermal amplification (RT-LAMP).
• Analysis of sensitivity, specificity, and operational requirements of reviewed techniques.

Main Results:

• CRISPR-based diagnostics, particularly when combined with RT-LAMP, show significant promise for SARS-CoV-2 detection.
• These methods offer rapid results without complex laboratory infrastructure.
• High sensitivity and specificity comparable to traditional methods are achievable.

Conclusions:

• RT-LAMP CRISPR-based diagnostics represent a viable and advantageous alternative for widespread COVID-19 testing.
• These technologies can improve global diagnostic capacity, especially in resource-limited settings.
• Further development and validation are crucial for clinical implementation.